US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist

27.530
-0.120-0.43%

Close Jun 14 16:00 ET

27.520
-0.010-0.04%

Post 19:59 ET

156.00BMarket Cap-550600P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Oct 1, 2023

(Q2)Jul 2, 2023

(Q1)Apr 2, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Oct 2, 2022

(Q2)Jul 3, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-9.91%1.09B

-70.27%8.7B

-38.93%5.24B

-42.07%3.46B

-114.79%-1.21B

-81.49%1.21B

-11.10%29.27B

44.70%8.58B

-46.53%5.97B

8.17B

Net income from continuing operations

-43.69%3.13B

-93.08%2.17B

-166.69%-3.34B

-127.63%-2.39B

-76.31%2.34B

-29.50%5.56B

39.81%31.4B

39.77%5B

5.79%8.64B

--9.88B

Depreciation and amortization

16.75%1.74B

24.21%6.29B

9.94%1.67B

31.87%1.56B

33.87%1.57B

25.27%1.49B

-2.45%5.06B

13.78%1.52B

-11.78%1.18B

--1.18B

Deferred tax

26.25%-441M

8.55%-3.44B

-409.04%-1.86B

-282.26%-113M

23.42%-873M

74.24%-598M

12.32%-3.76B

46.56%-365M

101.65%62M

---1.14B

Other non cash items

-253.00%-353M

-970.00%-4.28B

-127.50%-3.07B

-228.00%-574M

-175.10%-537M

-124.45%-100M

91.48%-400M

-47.27%-1.35B

89.68%-175M

--715M

Change In working capital

39.42%-3.34B

61.48%-2.17B

246.03%8.45B

73.85%-1.2B

-41.58%-3.92B

-654.38%-5.51B

-144.04%-5.64B

26.07%2.44B

-167.78%-4.59B

---2.77B

-Change in receivables

----

32.95%347M

----

106.85%261M

----

-Change in inventory

----

-97.80%-1.17B

----

47.47%-591M

----

-Change in payables and accrued expense

----

-125.19%-300M

----

-4.11%1.19B

----

-Change in other current assets

----

85.29%-663M

----

-326.30%-4.51B

----

-Change in other current liabilities

----

141.06%595M

----

-107.74%-1.45B

----

-Change in other working capital

----

-80.18%-982M

----

53.26%-545M

----

Cash from discontinued investing activities

Operating cash flow

-10.07%1.09B

-70.27%8.7B

-38.94%5.24B

-42.15%3.46B

-114.79%-1.21B

-81.47%1.21B

-10.17%29.27B

45.11%8.58B

-44.83%5.97B

--8.17B

Investing cash flow

Cash flow from continuing investing activities

-47.80%1.73B

-104.50%-32.28B

-149.31%-11B

242.40%890M

-125.26%-25.49B

484.83%3.32B

29.96%-15.78B

-70.84%-4.41B

93.79%-625M

-11.31B

Net PPE purchase and sale

38.19%-704M

-20.74%-3.91B

-4.30%-1.04B

3.69%-810M

-21.70%-914M

-77.14%-1.14B

-19.37%-3.24B

0.10%-1B

-36.08%-841M

---751M

Net business purchase and sale

--3.49B

-88.85%-43.43B

-158.79%-43.41B

--0

---25M

--0

---23B

---16.77B

--0

Net investment purchase and sale

-123.61%-1.06B

128.06%15.24B

150.40%33.44B

137.14%1.35B

-129.11%-24.02B

-39.94%4.47B

134.24%6.68B

911.79%13.35B

60.29%-3.64B

---10.49B

Net other investing changes

105.26%1M

6.25%-180M

66.67%15M

413.51%348M

-580.52%-524M

-46.15%-19M

37.25%-192M

-86.15%9M

62.88%-111M

---77M

Cash from discontinued investing activities

Investing cash flow

-47.75%1.73B

-104.51%-32.28B

-149.34%-11B

241.63%888M

-125.27%-25.49B

484.66%3.32B

30.00%-15.78B

-70.53%-4.41B

93.78%-627M

---11.31B

Financing cash flow

Cash flow from continuing financing activities

-77.95%-4.93B

275.72%26.07B

208.51%5.44B

34.40%-3.78B

977.95%27.18B

57.88%-2.77B

-51.12%-14.83B

-49.66%-5.02B

-422.78%-5.76B

2.52B

Net issuance payments of debt

-6,690.63%-2.17B

1,122.33%35.95B

379.98%7.78B

59.44%-1.43B

542.59%29.63B

98.25%-32M

-218.77%-3.52B

-103.74%-2.78B

-563.90%-3.52B

--4.61B

Net common stock issuance

----

--0

----

---2B

--0

Cash dividends paid

-3.00%-2.37B

-2.94%-9.25B

-3.12%-2.32B

-3.07%-2.31B

-3.16%-2.32B

-2.40%-2.3B

-2.91%-8.98B

-2.56%-2.25B

-2.75%-2.25B

---2.24B

Net other financing activities

11.47%-386M

-88.66%-632M

-357.14%-18M

-840.00%-37M

-192.16%-141M

12.80%-436M

-2,193.75%-335M

-96.52%7M

-98.46%5M

--153M

Cash from discontinued financing activities

Financing cash flow

-77.95%-4.93B

275.72%26.07B

208.51%5.44B

34.40%-3.78B

978.33%27.17B

57.87%-2.77B

-51.12%-14.83B

-49.66%-5.02B

-423.25%-5.76B

--2.52B

Net cash flow

Beginning cash position

523.29%2.92B

-76.40%468M

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

8.66%1.98B

-34.22%1.34B

-24.57%1.82B

--2.51B

Current changes in cash

-220.10%-2.11B

284.37%2.49B

62.68%-315M

236.96%567M

177.21%481M

230.70%1.76B

-722.12%-1.35B

-3,416.67%-844M

-19.31%-414M

---623M

Effect of exchange rate changes

-1,300.00%-28M

75.76%-40M

96.15%-1M

55.56%-32M

92.42%-5M

-100.00%-2M

-179.66%-165M

3.70%-26M

-94.59%-72M

---66M

End cash Position

-64.90%780M

523.29%2.92B

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

-34.22%1.34B

--1.82B

Free cash flow

428.77%386M

-81.59%4.79B

-44.65%4.2B

-48.45%2.65B

-128.60%-2.12B

-98.76%73M

-12.85%26.03B

54.34%7.58B

-49.73%5.13B

--7.42B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Oct 1, 2023	(Q2)Jul 2, 2023	(Q1)Apr 2, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Oct 2, 2022	(Q2)Jul 3, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-9.91%1.09B	-70.27%8.7B	-38.93%5.24B	-42.07%3.46B	-114.79%-1.21B	-81.49%1.21B	-11.10%29.27B	44.70%8.58B	-46.53%5.97B	8.17B
Net income from continuing operations	-43.69%3.13B	-93.08%2.17B	-166.69%-3.34B	-127.63%-2.39B	-76.31%2.34B	-29.50%5.56B	39.81%31.4B	39.77%5B	5.79%8.64B	--9.88B
Depreciation and amortization	16.75%1.74B	24.21%6.29B	9.94%1.67B	31.87%1.56B	33.87%1.57B	25.27%1.49B	-2.45%5.06B	13.78%1.52B	-11.78%1.18B	--1.18B
Deferred tax	26.25%-441M	8.55%-3.44B	-409.04%-1.86B	-282.26%-113M	23.42%-873M	74.24%-598M	12.32%-3.76B	46.56%-365M	101.65%62M	---1.14B
Other non cash items	-253.00%-353M	-970.00%-4.28B	-127.50%-3.07B	-228.00%-574M	-175.10%-537M	-124.45%-100M	91.48%-400M	-47.27%-1.35B	89.68%-175M	--715M
Change In working capital	39.42%-3.34B	61.48%-2.17B	246.03%8.45B	73.85%-1.2B	-41.58%-3.92B	-654.38%-5.51B	-144.04%-5.64B	26.07%2.44B	-167.78%-4.59B	---2.77B
-Change in receivables	----	32.95%347M	----	----	----	----	106.85%261M	----	----	----
-Change in inventory	----	-97.80%-1.17B	----	----	----	----	47.47%-591M	----	----	----
-Change in payables and accrued expense	----	-125.19%-300M	----	----	----	----	-4.11%1.19B	----	----	----
-Change in other current assets	----	85.29%-663M	----	----	----	----	-326.30%-4.51B	----	----	----
-Change in other current liabilities	----	141.06%595M	----	----	----	----	-107.74%-1.45B	----	----	----
-Change in other working capital	----	-80.18%-982M	----	----	----	----	53.26%-545M	----	----	----
Cash from discontinued investing activities		0					0
Operating cash flow	-10.07%1.09B	-70.27%8.7B	-38.94%5.24B	-42.15%3.46B	-114.79%-1.21B	-81.47%1.21B	-10.17%29.27B	45.11%8.58B	-44.83%5.97B	--8.17B
Investing cash flow
Cash flow from continuing investing activities	-47.80%1.73B	-104.50%-32.28B	-149.31%-11B	242.40%890M	-125.26%-25.49B	484.83%3.32B	29.96%-15.78B	-70.84%-4.41B	93.79%-625M	-11.31B
Net PPE purchase and sale	38.19%-704M	-20.74%-3.91B	-4.30%-1.04B	3.69%-810M	-21.70%-914M	-77.14%-1.14B	-19.37%-3.24B	0.10%-1B	-36.08%-841M	---751M
Net business purchase and sale	--3.49B	-88.85%-43.43B	-158.79%-43.41B	--0	---25M	--0	---23B	---16.77B	--0	--0
Net investment purchase and sale	-123.61%-1.06B	128.06%15.24B	150.40%33.44B	137.14%1.35B	-129.11%-24.02B	-39.94%4.47B	134.24%6.68B	911.79%13.35B	60.29%-3.64B	---10.49B
Net other investing changes	105.26%1M	6.25%-180M	66.67%15M	413.51%348M	-580.52%-524M	-46.15%-19M	37.25%-192M	-86.15%9M	62.88%-111M	---77M
Cash from discontinued investing activities
Investing cash flow	-47.75%1.73B	-104.51%-32.28B	-149.34%-11B	241.63%888M	-125.27%-25.49B	484.66%3.32B	30.00%-15.78B	-70.53%-4.41B	93.78%-627M	---11.31B
Financing cash flow
Cash flow from continuing financing activities	-77.95%-4.93B	275.72%26.07B	208.51%5.44B	34.40%-3.78B	977.95%27.18B	57.88%-2.77B	-51.12%-14.83B	-49.66%-5.02B	-422.78%-5.76B	2.52B
Net issuance payments of debt	-6,690.63%-2.17B	1,122.33%35.95B	379.98%7.78B	59.44%-1.43B	542.59%29.63B	98.25%-32M	-218.77%-3.52B	-103.74%-2.78B	-563.90%-3.52B	--4.61B
Net common stock issuance	----	--0	--0	--0	----	----	---2B	--0	--0	--0
Cash dividends paid	-3.00%-2.37B	-2.94%-9.25B	-3.12%-2.32B	-3.07%-2.31B	-3.16%-2.32B	-2.40%-2.3B	-2.91%-8.98B	-2.56%-2.25B	-2.75%-2.25B	---2.24B
Net other financing activities	11.47%-386M	-88.66%-632M	-357.14%-18M	-840.00%-37M	-192.16%-141M	12.80%-436M	-2,193.75%-335M	-96.52%7M	-98.46%5M	--153M
Cash from discontinued financing activities
Financing cash flow	-77.95%-4.93B	275.72%26.07B	208.51%5.44B	34.40%-3.78B	978.33%27.17B	57.87%-2.77B	-51.12%-14.83B	-49.66%-5.02B	-423.25%-5.76B	--2.52B
Net cash flow
Beginning cash position	523.29%2.92B	-76.40%468M	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	8.66%1.98B	-34.22%1.34B	-24.57%1.82B	--2.51B
Current changes in cash	-220.10%-2.11B	284.37%2.49B	62.68%-315M	236.96%567M	177.21%481M	230.70%1.76B	-722.12%-1.35B	-3,416.67%-844M	-19.31%-414M	---623M
Effect of exchange rate changes	-1,300.00%-28M	75.76%-40M	96.15%-1M	55.56%-32M	92.42%-5M	-100.00%-2M	-179.66%-165M	3.70%-26M	-94.59%-72M	---66M
End cash Position	-64.90%780M	523.29%2.92B	523.29%2.92B	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	-76.40%468M	-34.22%1.34B	--1.82B
Free cash flow	428.77%386M	-81.59%4.79B	-44.65%4.2B	-48.45%2.65B	-128.60%-2.12B	-98.76%73M	-12.85%26.03B	54.34%7.58B	-49.73%5.13B	--7.42B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall